1. Home
  2. ARWR vs AVAV Comparison

ARWR vs AVAV Comparison

Compare ARWR & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$82.73

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

HOLD

Current Price

$167.80

Market Cap

8.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARWR
AVAV
Founded
2003
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
8.6B
IPO Year
2009
2006

Fundamental Metrics

Financial Performance
Metric
ARWR
AVAV
Price
$82.73
$167.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
17
Target Price
$83.40
$316.88
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
05-07-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
99.80
N/A
EPS
N/A
N/A
Revenue
$16,142,321.00
N/A
Revenue This Year
N/A
$135.55
Revenue Next Year
N/A
$14.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.30
$135.20
52 Week High
$84.55
$417.86

Technical Indicators

Market Signals
Indicator
ARWR
AVAV
Relative Strength Index (RSI) 62.81 50.68
Support Level $70.05 $156.00
Resistance Level $83.40 $220.08
Average True Range (ATR) 4.01 9.27
MACD 0.37 -1.73
Stochastic Oscillator 88.90 66.26

Price Performance

Historical Comparison
ARWR
AVAV

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

Share on Social Networks: